Glycative Stress, Glycated Hemoglobin, and Atherogenic Dyslipidemia in Patients with Hyperlipidemia.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI

Hyperlipidemias* ; Diabetes Mellitus* ; Dyslipidemias* ; Atherosclerosis*; Humans ; Glycated Hemoglobin ; Cholesterol, LDL ; Cholesterol ; Triglycerides ; Cholesterol, HDL

(1) Background: Diabetes mellitus (DM) is a significant health problem and is associated with dyslipidemia; however, the association between glycative stress, in terms of glycated hemoglobin (HbA1c), and atherogenic dyslipidemia in hyperlipidemic patients with and without DM has rarely been reported. (2) Methods: We prospectively recruited 949 hyperlipidemic patients from the Lipid Clinic of the National Taiwan University Hospital. HbA1c and fasting serum lipids, including total cholesterol (TC), high- and low-density lipoprotein cholesterol (HDL-C and LDL-C), small dense LDL-C (sdLDL-C), very low-density lipoprotein cholesterol (VLDL-C), triglycerides, and advanced glycation end-products (AGEs), were measured. After fasting for 10-14 h, all subjects except those with DM underwent a standard oral glucose tolerance test (OGTT) with 75 g of glucose loading. All subjects were asked to discontinue the use of lipid-lowering agents for 8 weeks before recruitment. (3) Results: Patients with DM had a higher prevalence of hypertension and higher levels of triglyceride, TC/HDL-C ratio, AGEs, VLDL-C, and sdLDL-C. Among patients with higher HbA1c, the serum VLDL-C, AGEs, and TC/HDL-C ratio were significantly higher than those with lower HbA1c. After adjustment for covariates, multiple logistic regression analyses revealed different groups of dysglycemia with higher HbA1c had a higher odds ratio for TC/HDL-C ≥ 5, sdLDL-C ≥ 75th percentile, VLDL-C ≥ 75th percentile and AGEs ≥ 75th percentile. (4) Conclusions: A higher HbA1c was associated with a significant increase in the risk of atherogenic dyslipidemia and AGEs levels in patients with hyperlipidemia. The findings can be very promising in clinical application.

Can J Diabetes. 2013 Oct;37(5):319-26. (PMID: 24500559)
Pract Lab Med. 2021 Jul 18;26:e00248. (PMID: 34368411)
Int J Cardiol. 2009 Jan 24;131(3):313-20. (PMID: 18221806)
BMJ Open. 2017 Jul 31;7(7):e015949. (PMID: 28760792)
Atherosclerosis. 2009 Nov;207(1):191-4. (PMID: 19464010)
Int J Cardiol. 2005 Feb 28;98(3):459-64. (PMID: 15708180)
Clin Chim Acta. 1970 Nov;30(2):407-13. (PMID: 4097855)
Diabetes Care. 2010 Jan;33 Suppl 1:S62-9. (PMID: 20042775)
Curr Opin Endocrinol Diabetes Obes. 2020 Apr;27(2):115-123. (PMID: 32073426)
Eur Heart J. 2017 Aug 21;38(32):2459-2472. (PMID: 28444290)
Diabetes Care. 2022 Jan 1;45(Suppl 1):S83-S96. (PMID: 34964868)
Curr Atheroscler Rep. 2011 Feb;13(1):23-30. (PMID: 21104165)
Circulation. 2019 Jun 18;139(25):e1082-e1143. (PMID: 30586774)
J Formos Med Assoc. 2019 Nov;118 Suppl 2:S83-S89. (PMID: 31351690)
Clin Chim Acta. 1970 Apr;28(1):203-8. (PMID: 5440285)
Rev Endocr Metab Disord. 2017 Mar;18(1):29-40. (PMID: 28000009)
Metabolism. 2014 Dec;63(12):1469-79. (PMID: 25242435)
Clin Nutr Res. 2015 Apr;4(2):97-103. (PMID: 25954730)
Biol Pharm Bull. 2016;39(1):1-24. (PMID: 26725424)
Biochim Biophys Acta Mol Basis Dis. 2019 Mar 1;1865(3):611-619. (PMID: 30611860)
Endocrinol Diabetes Nutr (Engl Ed). 2018 Nov;65(9):540-545. (PMID: 30077632)
Arterioscler Thromb Vasc Biol. 2014 May;34(5):1069-77. (PMID: 24558110)
Diabetes Care. 2003 Jan;26 Suppl 1:S5-20. (PMID: 12502614)
Clin Chim Acta. 2006 Apr;366(1-2):269-73. (PMID: 16343471)
J Formos Med Assoc. 2019 Nov;118 Suppl 2:S66-S73. (PMID: 31300322)
N Engl J Med. 2010 Mar 4;362(9):800-11. (PMID: 20200384)
Am J Cardiol. 2001 Oct 1;88(7):737-43. (PMID: 11589839)
Diabetologia. 2001 Feb;44(2):129-46. (PMID: 11270668)
J Atheroscler Thromb. 2019 Jul 1;26(7):624-635. (PMID: 30587667)
Curr Vasc Pharmacol. 2012 Nov;10(6):684-6. (PMID: 23259553)
Atherosclerosis. 2019 Nov;290:140-205. (PMID: 31591002)

Keywords: HbA1c; advanced glycation end-products; atherogenic dyslipidemia; glycative stress

0 (Glycated Hemoglobin)
0 (Cholesterol, LDL)
97C5T2UQ7J (Cholesterol)
0 (Triglycerides)
0 (Cholesterol, HDL)

Date Created: 20230225 Date Completed: 20230228 Latest Revision: 20230328

20250114

PMC9954063

10.3390/cells12040640

36831307